Literature DB >> 31557383

Bifunctional Small-Molecule Ligands of K-Ras Induce Its Association with Immunophilin Proteins.

Ziyang Zhang1, Kevan M Shokat1.   

Abstract

Here we report the design, synthesis, and characterization of bifunctional chemical ligands that induce the association of Ras with ubiquitously expressed immunophilin proteins such as FKBP12 and cyclophilin A. We show this approach is applicable to two distinct Ras ligand scaffolds, and that both the identity of the immunophilin ligand and the linker chemistry affect compound efficacy in biochemical and cellular contexts. These ligands bind to Ras in an immunophilin-dependent fashion and mediate the formation of tripartite complexes of Ras, immunophilin, and the ligand. The recruitment of cyclophilin A to GTP-bound Ras blocks its interaction with B-Raf in biochemical assays. Our study demonstrates the feasibility of ligand-induced association of Ras with intracellular proteins and suggests it as a promising therapeutic strategy for Ras-driven cancers.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Ras; cancer; dimerization; drug design; immunophilin

Mesh:

Substances:

Year:  2019        PMID: 31557383      PMCID: PMC6980260          DOI: 10.1002/anie.201910124

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   16.823


  31 in total

1.  Structural determinants of Ras-Raf interaction analyzed in live cells.

Authors:  Tzvetanka Bondeva; András Balla; Péter Várnai; Tamas Balla
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

2.  Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity.

Authors:  Till Maurer; Lindsay S Garrenton; Angela Oh; Keith Pitts; Daniel J Anderson; Nicholas J Skelton; Benjamin P Fauber; Borlan Pan; Shiva Malek; David Stokoe; Mary J C Ludlam; Krista K Bowman; Jiansheng Wu; Anthony M Giannetti; Melissa A Starovasnik; Ira Mellman; Peter K Jackson; Joachim Rudolph; Weiru Wang; Guowei Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

3.  Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State.

Authors:  Matthew P Patricelli; Matthew R Janes; Lian-Sheng Li; Rasmus Hansen; Ulf Peters; Linda V Kessler; Yuching Chen; Jeff M Kucharski; Jun Feng; Tess Ely; Jeffrey H Chen; Sarah J Firdaus; Anjali Babbar; Pingda Ren; Yi Liu
Journal:  Cancer Discov       Date:  2016-01-06       Impact factor: 39.397

4.  A Chemical Biology View of Bioactive Small Molecules and a Binder-Based Approach to Connect Biology to Precision Medicines.

Authors:  Stuart L Schreiber
Journal:  Isr J Chem       Date:  2018-10-30       Impact factor: 3.333

5.  FKBP12 binds to acylated H-ras and promotes depalmitoylation.

Authors:  Ian M Ahearn; Frederick D Tsai; Helen Court; Mo Zhou; Benjamin C Jennings; Mahiuddin Ahmed; Nicole Fehrenbacher; Maurine E Linder; Mark R Philips
Journal:  Mol Cell       Date:  2011-01-21       Impact factor: 17.970

6.  Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.

Authors:  Matthew R Janes; Jingchuan Zhang; Lian-Sheng Li; Rasmus Hansen; Ulf Peters; Xin Guo; Yuching Chen; Anjali Babbar; Sarah J Firdaus; Levan Darjania; Jun Feng; Jeffrey H Chen; Shuangwei Li; Shisheng Li; Yun O Long; Carol Thach; Yuan Liu; Ata Zarieh; Tess Ely; Jeff M Kucharski; Linda V Kessler; Tao Wu; Ke Yu; Yi Wang; Yvonne Yao; Xiaohu Deng; Patrick P Zarrinkar; Dirk Brehmer; Dashyant Dhanak; Matthew V Lorenzi; Dana Hu-Lowe; Matthew P Patricelli; Pingda Ren; Yi Liu
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

7.  Two distinct Raf domains mediate interaction with Ras.

Authors:  T R Brtva; J K Drugan; S Ghosh; R S Terrell; S Campbell-Burk; R M Bell; C J Der
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

8.  In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction.

Authors:  Fumi Shima; Yoko Yoshikawa; Min Ye; Mitsugu Araki; Shigeyuki Matsumoto; Jingling Liao; Lizhi Hu; Takeshi Sugimoto; Yuichi Ijiri; Azusa Takeda; Yuko Nishiyama; Chie Sato; Shin Muraoka; Atsuo Tamura; Tsutomu Osoda; Ken-ichiro Tsuda; Tomoya Miyakawa; Hiroaki Fukunishi; Jiro Shimada; Takashi Kumasaka; Masaki Yamamoto; Tohru Kataoka
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

9.  A mammalian protein targeted by G1-arresting rapamycin-receptor complex.

Authors:  E J Brown; M W Albers; T B Shin; K Ichikawa; C T Keith; W S Lane; S L Schreiber
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

10.  Exceptionally high-affinity Ras binders that remodel its effector domain.

Authors:  John H McGee; So Youn Shim; Seung-Joo Lee; Paige K Swanson; Sam Y Jiang; Michael A Durney; Gregory L Verdine
Journal:  J Biol Chem       Date:  2017-12-27       Impact factor: 5.157

View more
  7 in total

Review 1.  Inhibition of Nonfunctional Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Attila Gursoy; Ozlem Keskin; Vadim Gaponenko
Journal:  Cell Chem Biol       Date:  2021-01-12       Impact factor: 8.116

Review 2.  Unifying principles of bifunctional, proximity-inducing small molecules.

Authors:  Christopher J Gerry; Stuart L Schreiber
Journal:  Nat Chem Biol       Date:  2020-03-20       Impact factor: 15.040

3.  SMALL MOLECULE IMAGING AGENT FOR MUTANT KRAS G12C.

Authors:  Peter D Koch; Jeremy Quintana; Maaz Ahmed; Rainer H Kohler; Ralph Weissleder
Journal:  Adv Ther (Weinh)       Date:  2021-03-12

Review 4.  PI3K Driver Mutations: A Biophysical Membrane-Centric Perspective.

Authors:  Mingzhen Zhang; Hyunbum Jang; Ruth Nussinov
Journal:  Cancer Res       Date:  2020-10-12       Impact factor: 13.312

Review 5.  Late-Stage Diversification of Natural Products.

Authors:  Benke Hong; Tuoping Luo; Xiaoguang Lei
Journal:  ACS Cent Sci       Date:  2020-04-22       Impact factor: 14.553

Review 6.  The current state of the art and future trends in RAS-targeted cancer therapies.

Authors:  Salman R Punekar; Vamsidhar Velcheti; Benjamin G Neel; Kwok-Kin Wong
Journal:  Nat Rev Clin Oncol       Date:  2022-08-26       Impact factor: 65.011

Review 7.  Mechanism of activation and the rewired network: New drug design concepts.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Chung-Jung Tsai; Bengi Ruken Yavuz; Nurcan Tuncbag; Hyunbum Jang
Journal:  Med Res Rev       Date:  2021-10-25       Impact factor: 12.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.